Gene Mutation and MRD-Directed Risk Stratification Treatment Improves Long Term Survival of the Patients with AML1-ETO-Positive AML

Gene Mutation and MRD-Directed Risk Stratification Treatment Improves Long Term Survival of the Patients with AML1-ETO-Positive AML

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Blood 2022-11, Vol.140 (Supplement 1), p.9097-9097
Hauptverfasser: Xu, Dan, Yang, Ying, Yin, Zhao, Tu, Sanfang, Nie, Danian, Sun, Qixin, Huang, Zhengqian, Zhang, Yu, Yu, Guopan
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 9097
container_issue Supplement 1
container_start_page 9097
container_title Blood
container_volume 140
creator Xu, Dan
Yang, Ying
Yin, Zhao
Tu, Sanfang
Nie, Danian
Sun, Qixin
Huang, Zhengqian
Zhang, Yu
Yu, Guopan
description
doi_str_mv 10.1182/blood-2022-159589
format Article
fullrecord <record><control><sourceid>elsevier_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1182_blood_2022_159589</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0006497122056567</els_id><sourcerecordid>S0006497122056567</sourcerecordid><originalsourceid>FETCH-LOGICAL-c1379-e88370ca546cf1ef39388f00a75047ee07a0595d5da3a669c52fd97c866da0123</originalsourceid><addsrcrecordid>eNp9kM9OAjEQhxujiYg-gLe-QHXaZf_FEwFEkiUQwPOmtrNShS1pyxrPvrgL69nTJDO_bzLzEXLP4YHzTDy-7azVTIAQjMd5nOUXpMdjkTEAAZekBwAJG-QpvyY33n8A8EEk4h75mWKNdH4MMhhbU1lrOl-N2dg4VAE1XRn_SdfBtePKqC60cSjDHutAZ_uDsw16Wtj6nW7Q7en66BrTyB21FQ1bpMuWaaOefpmwpcN5wdlks2BL600wDZ46t-SqkjuPd3-1T16fJ5vRCysW09loWDDFozRnmGVRCkrGg0RVHKsoj7KsApBpDIMUEVIJ7es61jKSSZKrWFQ6T1WWJFoCF1Gf8G6vctZ7h1V5cGYv3XfJoTxZLM8Wy5PFsrPYMk8dg-1hjUFXetX-o1CfDZXamn_oXyaeerA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Gene Mutation and MRD-Directed Risk Stratification Treatment Improves Long Term Survival of the Patients with AML1-ETO-Positive AML</title><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Alma/SFX Local Collection</source><creator>Xu, Dan ; Yang, Ying ; Yin, Zhao ; Tu, Sanfang ; Nie, Danian ; Sun, Qixin ; Huang, Zhengqian ; Zhang, Yu ; Yu, Guopan</creator><creatorcontrib>Xu, Dan ; Yang, Ying ; Yin, Zhao ; Tu, Sanfang ; Nie, Danian ; Sun, Qixin ; Huang, Zhengqian ; Zhang, Yu ; Yu, Guopan</creatorcontrib><identifier>ISSN: 0006-4971</identifier><identifier>EISSN: 1528-0020</identifier><identifier>DOI: 10.1182/blood-2022-159589</identifier><language>eng</language><publisher>Elsevier Inc</publisher><ispartof>Blood, 2022-11, Vol.140 (Supplement 1), p.9097-9097</ispartof><rights>2022 The American Society of Hematology</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids></links><search><creatorcontrib>Xu, Dan</creatorcontrib><creatorcontrib>Yang, Ying</creatorcontrib><creatorcontrib>Yin, Zhao</creatorcontrib><creatorcontrib>Tu, Sanfang</creatorcontrib><creatorcontrib>Nie, Danian</creatorcontrib><creatorcontrib>Sun, Qixin</creatorcontrib><creatorcontrib>Huang, Zhengqian</creatorcontrib><creatorcontrib>Zhang, Yu</creatorcontrib><creatorcontrib>Yu, Guopan</creatorcontrib><title>Gene Mutation and MRD-Directed Risk Stratification Treatment Improves Long Term Survival of the Patients with AML1-ETO-Positive AML</title><title>Blood</title><issn>0006-4971</issn><issn>1528-0020</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><recordid>eNp9kM9OAjEQhxujiYg-gLe-QHXaZf_FEwFEkiUQwPOmtrNShS1pyxrPvrgL69nTJDO_bzLzEXLP4YHzTDy-7azVTIAQjMd5nOUXpMdjkTEAAZekBwAJG-QpvyY33n8A8EEk4h75mWKNdH4MMhhbU1lrOl-N2dg4VAE1XRn_SdfBtePKqC60cSjDHutAZ_uDsw16Wtj6nW7Q7en66BrTyB21FQ1bpMuWaaOefpmwpcN5wdlks2BL600wDZ46t-SqkjuPd3-1T16fJ5vRCysW09loWDDFozRnmGVRCkrGg0RVHKsoj7KsApBpDIMUEVIJ7es61jKSSZKrWFQ6T1WWJFoCF1Gf8G6vctZ7h1V5cGYv3XfJoTxZLM8Wy5PFsrPYMk8dg-1hjUFXetX-o1CfDZXamn_oXyaeerA</recordid><startdate>20221115</startdate><enddate>20221115</enddate><creator>Xu, Dan</creator><creator>Yang, Ying</creator><creator>Yin, Zhao</creator><creator>Tu, Sanfang</creator><creator>Nie, Danian</creator><creator>Sun, Qixin</creator><creator>Huang, Zhengqian</creator><creator>Zhang, Yu</creator><creator>Yu, Guopan</creator><general>Elsevier Inc</general><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>20221115</creationdate><title>Gene Mutation and MRD-Directed Risk Stratification Treatment Improves Long Term Survival of the Patients with AML1-ETO-Positive AML</title><author>Xu, Dan ; Yang, Ying ; Yin, Zhao ; Tu, Sanfang ; Nie, Danian ; Sun, Qixin ; Huang, Zhengqian ; Zhang, Yu ; Yu, Guopan</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c1379-e88370ca546cf1ef39388f00a75047ee07a0595d5da3a669c52fd97c866da0123</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Xu, Dan</creatorcontrib><creatorcontrib>Yang, Ying</creatorcontrib><creatorcontrib>Yin, Zhao</creatorcontrib><creatorcontrib>Tu, Sanfang</creatorcontrib><creatorcontrib>Nie, Danian</creatorcontrib><creatorcontrib>Sun, Qixin</creatorcontrib><creatorcontrib>Huang, Zhengqian</creatorcontrib><creatorcontrib>Zhang, Yu</creatorcontrib><creatorcontrib>Yu, Guopan</creatorcontrib><collection>CrossRef</collection><jtitle>Blood</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Xu, Dan</au><au>Yang, Ying</au><au>Yin, Zhao</au><au>Tu, Sanfang</au><au>Nie, Danian</au><au>Sun, Qixin</au><au>Huang, Zhengqian</au><au>Zhang, Yu</au><au>Yu, Guopan</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Gene Mutation and MRD-Directed Risk Stratification Treatment Improves Long Term Survival of the Patients with AML1-ETO-Positive AML</atitle><jtitle>Blood</jtitle><date>2022-11-15</date><risdate>2022</risdate><volume>140</volume><issue>Supplement 1</issue><spage>9097</spage><epage>9097</epage><pages>9097-9097</pages><issn>0006-4971</issn><eissn>1528-0020</eissn><pub>Elsevier Inc</pub><doi>10.1182/blood-2022-159589</doi><tpages>1</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0006-4971
ispartof Blood, 2022-11, Vol.140 (Supplement 1), p.9097-9097
issn 0006-4971
1528-0020
language eng
recordid cdi_crossref_primary_10_1182_blood_2022_159589
source Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Alma/SFX Local Collection
title Gene Mutation and MRD-Directed Risk Stratification Treatment Improves Long Term Survival of the Patients with AML1-ETO-Positive AML
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-04T04%3A33%3A35IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-elsevier_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Gene%20Mutation%20and%20MRD-Directed%20Risk%20Stratification%20Treatment%20Improves%20Long%20Term%20Survival%20of%20the%20Patients%20with%20AML1-ETO-Positive%20AML&rft.jtitle=Blood&rft.au=Xu,%20Dan&rft.date=2022-11-15&rft.volume=140&rft.issue=Supplement%201&rft.spage=9097&rft.epage=9097&rft.pages=9097-9097&rft.issn=0006-4971&rft.eissn=1528-0020&rft_id=info:doi/10.1182/blood-2022-159589&rft_dat=%3Celsevier_cross%3ES0006497122056567%3C/elsevier_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rft_els_id=S0006497122056567&rfr_iscdi=true